Becker's Healthcare December 7, 2018
Anuja Vaidya

The FDA formally recognized Clinical Genome Resource consortium’s ClinGen Expert Curated Human Genetic Data, a public genomic database, as a source of valid scientific evidence.

Evidence from the database, which is funded by the National Institutes of Health, can now be used to support clinical validity in premarket FDA submissions. Test developers can use information from the database rather than having to generate information for themselves. Additionally, test developers will not have to demonstrate the reliability of the database to the agency.

In April, the FDA issued a final guidance that showcased the benefits of public databases for the accelerated development of genetic tests. The agency recognized the ClinGen database using the process detailed in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Precision Medicine, Provider, Regulations, Technology
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article